Advertisement

Topics

Acticor Biotech Company Profile

02:04 EST 22nd February 2019 | BioPortfolio

Acticor Biotech is a clinical stage biotechnology company, spin-off of INSERM, dedicated to developing an innovative treatment in the therapy of acute thrombotic diseases, including ischemic stroke and pulmonary embolism. Acticor Biotech is built upon the expertise and the results of researches conducted by, the founders: Dr. Martine Jandrot-Perrus at INSERM Paris and Pr. Philippe Billiald at Paris-Sud University.For more information, go to: https://acticor-biotech.com/


News Articles [1513 Associated News Articles listed on BioPortfolio]

Acticor raises €1.7mm through undisclosed round

Acticor Biotech SAS (mAb therapeutics to treat ischemic stroke) completed a €1.7mm ($2mm) undisclosed round from Primer Capital, along with returning backers Anaxago, CapDecisif Management, and othe...

Stroke-focused Acticor closes €590k seed round

Ischemic stroke-focused start-up Acticor Biotech SAS (developing a monoclonal antibody with antiplatelet activity) raised €590k ($661k) through its seed round. Two-thirds of the money was from the c...

Acticor Biotech Appoints Dr Andrea Comenducci as Medical Director

Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombo-embolic diseases, including stroke and pulmonary embolism, today announced the appoi...

French Acticor Biotech raises €15.3m

Acticor closes €15.3mm Series B round; could get another €5mm

Acticor Biotech SAS (antibody therapeutics for acute thrombotic diseases, including ischemic stroke and pulmonary embolism) closed a €15.3mm ($17.7mm) Series B round led by new backers Newton BioCap...

Acticor early round raises €1.4mm; later adds on €1.5mm

Acticor Biotech SAS (MAb therapeutics to treat ischemic stroke) completed an undisclosed €1.4mm ($1.55mm) capital increase assumed to be its Series A round, from investors via the Anaxago crowdfundi...

Acticor Biotech Raises €15.3M In a Series B Financing

New financing will enable the company to launch shortly the first Phase II clinical trial of its lead candidate ACT017 inhibiting GPVI in acute ischemic stroke Acticor ...

Acticor Biotech SAS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryActicor Biotech SAS Acticor, a subsidiary of MabDesign is a biopharmaceutical company that develops innovative therapeutic strategy for the emergency treatment of ischemic strokes. The company ...

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Prestalia [marina biotech]

These highlights do not include all the information needed to use PRESTALIA tablets safely and effectively. See full prescribing information for PRESTALIA.PRESTALIA (perindopril arginine and amlodipin...

Pyridostigmine bromide [rising pharmaceuticals, inc.]

Pyridostigmine Bromide Extended-Release Tablets, 180 mg

Vivotif-b [rebel distributors corp]

Vivotif-B

Stelara [janssen biotech, inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) injection, for subcutaneous or int...

Ctx4 gel 5000 [oral biotech]

CariFree® CTx4 Gel 50001.1% (w/w) sodium fluoride

Clinical Trials [16 Associated Clinical Trials listed on BioPortfolio]

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine

The purpose of this study is to evaluate the 5-year Immune Persistence of Inactivated Enterovirus Type 71 (EV71) Vaccine manufactured by Sinovac (Beijing) Biotech Co., Ltd.

Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

This phase I clinical study was designed to evaluate the safety of Recombinant Human Papillomavirus Vaccine (6,11,16,18,31,33,45,52,58 Type)(E.Coli)(hereafter called HPV vaccine), manufact...

Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream

Welichem Biotech has developed a small molecule drug candidate, WBI-1001, that selectively targets the pathogenic features of inflammatory skin diseases, including atopic dermatitis (a for...

Companies [935 Associated Companies listed on BioPortfolio]

Acticor Biotech

Acticor Biotech is a clinical stage biotechnology company, spin-off of INSERM, dedicated to developing an innovative treatment in the therapy of acute thrombotic diseases, includi...

BioTech Umeå

The Biotech industry stimulates growth and creates new job opportunities in Sweden. The city of Umeå hosts first-rate biotech research. BioTech Umeå is a driving force helping the industry as well a...

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...

M-Biotech, Inc.

M-Biotech was founded in 1997 and is located in Salt Lake City, Utah. M-Biotech's core business includes the research and development of biosensors for health care applications. Based on M-Biotech's p...

Nascent Biotech, Inc.

Nascent Biotech, Inc is a clinical-stage biotech company engaged in the development of monoclonal antibodies to be used in the treatment of various cancers. Its products are not c...

More Information about "Acticor Biotech" on BioPortfolio

We have published hundreds of Acticor Biotech news stories on BioPortfolio along with dozens of Acticor Biotech Clinical Trials and PubMed Articles about Acticor Biotech for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Acticor Biotech Companies in our database. You can also find out about relevant Acticor Biotech Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record